XML 46 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments Measured At Fair Value (Tables)
9 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Assets And Liabilities Measured At Fair Value On A Recurring Basis
The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of March 31, 2018: 
 
Total
 
Quoted
prices in
active
markets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
7,070

 
$
7,070

 
$

 
$

Forward foreign currency contracts
18

 

 
18

 

Available for sale securities
812

 
812

 

 

Total
$
7,900

 
$
7,882

 
$
18

 
$

Liabilities:
 
 
 
 
 
 
 
Forward foreign currency contracts
$
636

 
$

 
$
636

 
$

Contingent consideration, non-current
4,884

 

 

 
4,884

Total
$
5,520

 
$

 
$
636

 
$
4,884



The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring basis as of June 30, 2017:
 
Total
 
Quoted
prices in
active
markets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
21,800

 
$
21,800

 
$

 
$

Forward foreign currency contracts
99

 

 
99

 

Available for sale securities
882

 
882

 

 

Total
$
22,781

 
$
22,682

 
$
99

 
$

Liabilities:
 
 
 
 
 
 
 
Forward foreign currency contracts
$
53

 
$

 
$
53

 
$

Contingent consideration, non-current
2,656

 

 

 
2,656

Total
$
2,709

 
$

 
$
53

 
$
2,656

Level 3 Activity
The following table summarizes the Level 3 activity for the nine months ended March 31, 2018.
        
Balance as of June 30, 2017
$
2,656

Fair value of initial contingent consideration(a)
1,547

Contingent consideration adjustment (b)
556

Translation adjustment
125

Balance as of March 31, 2018
$
4,884



(a) In connection with the acquisition of Clarks during fiscal 2018, payment of a portion of the purchase price is contingent upon the achievement of certain operating results. Contingent consideration of up to a maximum of £1,500 is payable based on the achievement of specified operating results over the 18-month period following completion of the acquisition.

(b) The change in the fair value of contingent consideration is included in “Acquisition related expenses, restructuring and integration charges” in the Company’s Consolidated Statements of Income.